VIVO
Weill Cornell Medical College
Index
Log in
Search form
Home
People
Organizations
Research
Support
Corroboration the efficacy observed in Project Part 1 and exploration of the mechanisms behind these effects
Grant
Overview
date/time interval
October 1, 2022 - September 30, 2024
awarded by
Boehringer Ingelheim Pharmaceuticals, Inc. (USA)
administered by
Radiation Oncology
sponsor award ID
SRA 225860-01
Affiliation
contributor
Demaria, Sandra
Principal Investigator
2022 - 2023